Method of treating cancer associated with a RAS mutation
US10238650B2 · kind B2 · utility
13Cited by
31References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 2, 2016 |
| Grant date | Mar 26, 2019 |
| Priority date | — |
| Expiry date | Mar 2, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are methods of treating a cancer characterized by expressing a mutant form of a RAS protein. Some embodiments relate to treatment of cancer by administering Plinabulin to a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.